Prevail Partners

Mary Schaheen, as President and Director, leads investment decisions at the firm. She is supported by Director and Chief Strategist Patrick J. Keenan, with advisory input from former FDA Commissioner Lester Crawford. The lean decision-making structure reflects the firm's concentrated portfolio approach.

The firm sources opportunities through deep regulatory networks, including the participation of former FDA Commissioner Lester Crawford on its advisory board. Active membership in regional industry groups like Life Sciences Pennsylvania and BioNJ further provides early visibility into emerging life sciences companies. The firm's in-house clinical trial capabilities also generate direct operational connections to early-stage biotech ventures.

Prevail Partners operates as an asset manager with a hybrid venture-and-services model, not a family office. The firm's architecture includes both a direct investment arm and an affiliated clinical trial services company, Prevail InfoWorks, which acts as an operational partner to portfolio companies rather than an external vendor.

Prevail InfoWorks is an affiliate company that provides clinical trial execution and management services. Portfolio companies of Prevail Partners can access these in-house services, creating an integrated model where capital investment is paired with operational support for regulatory navigation and trial management. This reduces the typical friction of outsourcing to third-party contract research organizations.

Prevail Partners targets early-stage and growth-stage companies, focusing on life sciences and technology sectors. The stage coverage spans from preclinical biotech companies requiring clinical trial support to growth-stage digital health platforms scaling their regulatory and commercial infrastructure.

Related philanthropic entities include the Peace of Mind Project and Shimojani Inc. While these share principal connections with Prevail Partners, they operate as separate legal and programmatic entities distinct from the for-profit investment activities of the management entity.

The firm's co-investment posture has not been publicly detailed in available records. Given its lean team and integrated service model, the firm has historically maintained a concentrated, direct-investment approach rather than widely syndicating deals. Its affiliate Prevail InfoWorks serves as the primary operational co-investor in the sense that it provides services alongside capital, though this is a related-party rather than a third-party arrangement.